One study utilized chitosan nanoparticles, a biocompatible and biodegradable polymer, as a carrier for doxorubicin and AOD 9604
OPPS Drug Acquisition Cost Survey Description and Burden Calculation From January 1, 2026, through March 31, 2026, we intend to survey hospitals paid under the OPPS for their drug acquisition costs, including for SCODs, and drugs and biologicals CMS historically treats as SCODs
"Today's announcement builds upon our historic Most Favored Nations drug pricing deals' goal of democratizing access to weight-loss medication, which has been out of reach for so many in need," CMS Administrator Mehmet Oz, MD, said in a statement in December 2025
Type I glass is preferred over plastic and soda-lime glass for research-grade reagent containment because it minimizes leachables and interactions with the contents